Sadiya Parveen
Overview
Explore the profile of Sadiya Parveen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parveen S, Shen J, Lun S, Zhao L, Alt J, Koleske B, et al.
Nat Commun
. 2023 Nov;
14(1):7427.
PMID: 37973991
As one of the most successful human pathogens, Mycobacterium tuberculosis (Mtb) has evolved a diverse array of determinants to subvert host immunity and alter host metabolic patterns. However, the mechanisms...
2.
Ordonez A, Saupe F, Kasper C, Turner M, Parveen S, Flavahan K, et al.
J Infect Dis
. 2023 Oct;
228(Suppl 4):S291-S296.
PMID: 37788499
Background: Microbial-based cancer treatments are an emerging field, with multiple bacterial species evaluated in animal models and some advancing to clinical trials. Noninvasive bacteria-specific imaging approaches can potentially support the...
3.
Parveen S, Shen J, Lun S, Zhao L, Koleske B, Leone R, et al.
bioRxiv
. 2023 Mar;
PMID: 36865287
As one of the most successful human pathogens, () has evolved a diverse array of determinants to subvert host immunity and alter host metabolic patterns. However, the mechanisms of pathogen...
4.
Parveen S, Lun S, Urbanowski M, Cardin M, Shen J, Murphy J, et al.
J Infect Dis
. 2021 May;
224(11):1962-1972.
PMID: 33955457
Myeloid-derived suppressor cells (MDSCs) are present in elevated numbers in tuberculosis patients and have been found to be permissive for Mycobacterium tuberculosis proliferation. To determine whether depletion of MDSCs may...
5.
Krug S, Parveen S, Bishai W
Front Immunol
. 2021 May;
12:660916.
PMID: 33953722
Following infection with , the causative agent of tuberculosis (TB), most human hosts are able to contain the infection and avoid progression to active TB disease through expression of a...
6.
Parveen S, Siddharth S, Cheung L, Kumar A, Shen J, Murphy J, et al.
Mol Oncol
. 2021 Mar;
15(5):1330-1344.
PMID: 33682324
In many solid tumors including triple-negative breast cancer (TNBC), upregulation of the interleukin-4 receptor (IL-4R) has been shown to promote cancer cell proliferation, apoptotic resistance, metastatic potential, and a Th2...
7.
Kumar P, Kumar A, Parveen S, Murphy J, Bishai W
Immunotherapy
. 2019 Jul;
11(13):1117-1128.
PMID: 31361167
T regulatory cells (Tregs) are an important T cell population for immune tolerance, prevention of autoimmune diseases and inhibition of antitumor immunity. The tumor-promoting role played by Tregs in cancer...
8.
Parveen S, Bishai W, Murphy J
Microbiol Spectr
. 2019 Jul;
7(4).
PMID: 31267892
Diphtheria is one of the most well studied of all the bacterial infectious diseases. These milestone studies of toxigenic along with its primary virulence determinant, diphtheria toxin, have established the...
9.
Kumar A, Parveen S, Sharma I, Pathak H, Deshmukh M, Sharp J, et al.
Biochim Biophys Acta Biomembr
. 2019 Apr;
1861(6):1260-1274.
PMID: 30951703
Background: Antibiotic resistance is a problem that necessitates the identification of new antimicrobial molecules. Milk is known to have molecules with antimicrobial properties (AMPs). Echidna Antimicrobial Protein (EchAMP) is one...
10.
Cheung L, Fu J, Kumar P, Kumar A, Urbanowski M, Ihms E, et al.
Proc Natl Acad Sci U S A
. 2019 Feb;
116(8):3100-3105.
PMID: 30718426
Denileukin diftitox (DAB-IL-2, Ontak) is a diphtheria-toxin-based fusion protein that depletes CD25-positive cells including regulatory T cells and has been approved for the treatment of persistent or recurrent cutaneous T...